- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02102945
Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest
CT Perfusion in the Prognostication of Patients in Coma Following Cardiac Arrest- A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiac arrest is common and is associated with poor survival despite intensive medical care. These patients are subjected to cooling therapy to improve neurological outcomes. After cooling these patients are allowed to spontaneously return to normal body temperature. From here on, the outcome of these patients is mainly dependent on a wait and watch approach as the clinical examination of patients in a coma is very limited. Despite these attempts, 41% of these patients die and only 55 % of them have a favourable neurological outcome.
There have been few clinical scoring systems to provide prognosis in the face of a cardiac arrest but none of them address the more serious group- those in coma. For patients in coma, their medications, particularly those that suppress the central nervous system, cause difficulty in their clinical assessment. Multiple ancillary tests, such as routine CT or MRI of brain, do not give any useful prognostic information. We hypothesize that the neurological outcome of patients in coma is mainly dependent on presence of brainstem function.
To the best of our knowledge, no study has addressed the issue of brainstem function in cardiac arrest patients. This may be due to the fact that there was no imaging tool which could confidently depict the function of the brainstem. In a recently performed study in our institution, using CT perfusion technique, we have demonstrated that patients with diffusely impaired brainstem perfusion have poor prognosis and do not survive. This study is already being considered by the World Health Organization for the modification of criteria for the declaration of brain death. We suggest that a similar imaging technique will potentially be useful in prognosticating patients in coma following cardiac arrest.
In the present pilot study, we propose to determine if performing CT perfusion scans in post-cardiac arrest patients in coma will help prognosticate the outcome in these patients. This may potentially help in early withdrawal of care in patients with significantly impaired brainstem function. If so, this will have a significant impact on patient care and can potentially have huge financial implications for the health care system. Such early decision making may also help in organ harvesting in suitable situations. This will potentially improve the quality of life in many other terminally ill patients.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jai JS Shankar, MD, DM
- Phone Number: 9027435448
- Email: JaiJai.Shankar@cdha.nshealth.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3A6
- Recruiting
- Queen Elizabeth II Health Sciences Centre-Halifax Infirmary
-
Principal Investigator:
- Jai JS Shankar, MD, DM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All adult patients (age range: 18-80 years), in a coma for at least 24 hours following cardiac arrest who are admitted to our cardiac intensive care unit and who have recovered body temperature back to normal after being subjected to the therapeutic hypothermia protocol will be included in the study.
- Also included are those patients whose next of kin have provided consent for the study.
Exclusion Criteria:
- patients who are pregnant,
- those with impaired renal function,
- those who have contraindications to the CT contrast media (such as a known allergy or anaphylactic reactions) and
- those who do not provide consent. Pregnant patients will be excluded to avoid any potential adverse effect of radiation from CT perfusion study on the developing foetus. A developing foetus is more vulnerable to radiation when compared to adult patients.
Patients above 80 years will be excluded to avoid age related comorbidities affecting the patients' survival.
We do not see patients below 18 years of age at our institution thus they will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Computed tomography perfusion
Participants will undergo CT perfusion of the head after cooling following cardiac arrest.
|
Computed tomography perfusion of the head
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical evaluation of brainstem function
Time Frame: 1 year
|
Clinical evaluation of brainstem function at the end of hospital stay.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of adverse events as a measure of safety and tolerability
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jai JS Shankar, MD, DM, Queen Elizabeth II Health Sciences Centre, Halifax Infirmary
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTP2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Death
-
Liu YonghongEnrolling by invitationSudden Unexpected Death in Epilepsy | Near-Sudden Unexpected Death in EpilepsyChina
-
Hospices Civils de LyonTerminatedSudden Unexpected Death in Epilepsy (SUDEP)France
-
Alexandria UniversityUnknownMaternal Death | Hypoxic Brain InjuryEgypt
-
NYU Langone HealthRecruiting
-
Centre Hospitalier Universitaire de NīmesTerminatedStress Disorders, Post-TraumaticFrance
-
Brigham and Women's HospitalNot yet recruitingEpilepsyUnited States
-
Indiana UniversityGreenwich Biosciences; Child Neurology FoundationCompleted
-
Fundació Institut de Recerca de l'Hospital de la...UnknownBiomarkers | Cardiac Sudden Death | Hypoxia Brain | Cell Membrane MicroparticlesSpain
-
Gorm GreisenCopenhagen Trial Unit, Center for Clinical Intervention Research; Elsass FoundationCompletedBrain Injuries | Infant, Extremely Premature | Death; Neonatal | Death, BrainDenmark
-
Instituto de Investigación Hospital Universitario...Hospital de Santa Maria, PortugalCompletedPrevention of Kidney Injury Associated With Brain DeathSpain, Portugal
Clinical Trials on Computed tomography perfusion
-
Stanford UniversitySiemens Healthcare QTCompletedMetastatic Renal Cell CancerUnited States
-
Assiut UniversityUnknown
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedHead and Neck Neoplasm | Malignant Head and Neck NeoplasmUnited States
-
University of WashingtonTerminatedPancreatic Ductal AdenocarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownHepatocellular CarcinomaFrance
-
Johns Hopkins UniversityToshiba Medical Systems Corporation, JapanWithdrawnIschemia | Coronary Artery DiseaseUnited States
-
National Institute of Cardiology, Warsaw, PolandCompletedMyocardial Ischemia | Percutaneous Coronary Intervention | Coronary Occlusion | Myocardial Perfusion ImagingPoland
-
University of EdinburghCompleted
-
Young-Hak Kim, MD, PhDRecruitingCoronary DiseaseKorea, Republic of
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States